AustralieFrV1, Main, Exploration, bibRecord, 007644

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

Identifieur interne : 007644 ( Main/Exploration ); précédent : 007643; suivant : 007645

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

Auteurs : Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; LISHENG LIU [République populaire de Chine] ; Christophe Tzourio [France] ; Mark Woodward [États-Unis] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Anthony Rodgers [Australie] ; John Chalmers [Australie]

Source :

Journal of hypertension [ 0263-6352 ] ; 2010.

RBID : Pascal:10-0104497

Descripteurs français

Pascal (Inist)
- Pathologie cérébrovasculaire, Accident cérébrovasculaire, Pathologie de l'appareil circulatoire, Périndopril, Pression artérielle, Pression sanguine, Indapamide, Hypertension artérielle, Antihypertenseur, Diurétique.

English descriptors

KwdEn :
- Antihypertensive agent, Arterial pressure, Blood pressure, Cardiovascular disease, Cerebrovascular disease, Diuretic, Hypertension, Indapamide, Perindopril, Stroke.

Abstract

Objective To assess the benefits of blood pressure (BP) lowering on vascular events separately for Asian and for Western participants with particular emphasis on stroke subtypes and cardiac outcomes. Methods This is a subsidiary analysis of Perindopril Protection Against Recurrent Stroke Study (PROGRESS), a randomized, placebo-controlled trial that established the benefits of BP lowering in 6105 patients with cerebrovascular disease, randomly assigned to either active treatment (perindopril for all, and indapamide for those with neither an indication for, nor a contraindication to, a diuretic) or placebo(s). Outcomes are total and cause-specific vascular outcomes. Results The annual rates for total major vascular events were 4.2% in Asian and 5.2% in Western participants. Overall stroke rates were greater in Asian compared to Western participants with proportionally more lacunar infarctions and haemorrhagic strokes in Asians and more cardio-embolic infarctions and large artery infarctions in Western participants. Active treatment reduced BP by 10.3/ 4.6 mmHg in Asian, and by 8.1/3.6 mmHg in Western participants. Among Asian participants there was a 38% [95% confidence interval (CI) 23-49%] reduction in major vascular events compared to a 20% (95% CI 7-31%) reduction in Western participants (P homogeneity = 0.06). Similarly, there were higher relative risk reductions for all other outcomes among Asian participants, but this only reached statistical significance for heart failure and vascular death (P= 0.02 for each). The number needed to treat for major vascular events over 5 years was 15 (95% CI 10-26) in Asian compared to 28 (95% CI 17-94) in Western participants (P homogeneity = 0.09). Conclusions BP lowering reduces the risk of major vascular events, with separately significant reductions, in both Asia and the West.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 002862
to stream PascalFrancis, to step Curation: 003724
to stream PascalFrancis, to step Checkpoint: 002158
to stream Main, to step Merge: 007C26
to stream Main, to step Curation: 007644

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial</title>
<author><name sortKey="Arima, Hisatomi" sort="Arima, Hisatomi" uniqKey="Arima H" first="Hisatomi" last="Arima">Hisatomi Arima</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Anderson, Craig" sort="Anderson, Craig" uniqKey="Anderson C" first="Craig" last="Anderson">Craig Anderson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Omae, Teruo" sort="Omae, Teruo" uniqKey="Omae T" first="Teruo" last="Omae">Teruo Omae</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>National Cardiovascular Center</s1>
<s2>Suita</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>National Cardiovascular Center</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lisheng Liu" sort="Lisheng Liu" uniqKey="Lisheng Liu" last="Lisheng Liu">LISHENG LIU</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Division of Hypertension, Fu Wai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>INSERM U708 and the Department of Neurology, Hôpital Lariboisière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name>
<affiliation wicri:level="2"><inist:fA14 i1="05"><s1>Mount Sinai School of Medicine</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Macmahon, Stephen" sort="Macmahon, Stephen" uniqKey="Macmahon S" first="Stephen" last="Macmahon">Stephen Macmahon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rodgers, Anthony" sort="Rodgers, Anthony" uniqKey="Rodgers A" first="Anthony" last="Rodgers">Anthony Rodgers</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0104497</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0104497 INIST</idno>
<idno type="RBID">Pascal:10-0104497</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002862</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003724</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002158</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">002158</idno>
<idno type="wicri:doubleKey">0263-6352:2010:Arima H:perindopril:based:blood</idno>
<idno type="wicri:Area/Main/Merge">007C26</idno>
<idno type="wicri:Area/Main/Curation">007644</idno>
<idno type="wicri:Area/Main/Exploration">007644</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial</title>
<author><name sortKey="Arima, Hisatomi" sort="Arima, Hisatomi" uniqKey="Arima H" first="Hisatomi" last="Arima">Hisatomi Arima</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Anderson, Craig" sort="Anderson, Craig" uniqKey="Anderson C" first="Craig" last="Anderson">Craig Anderson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Omae, Teruo" sort="Omae, Teruo" uniqKey="Omae T" first="Teruo" last="Omae">Teruo Omae</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>National Cardiovascular Center</s1>
<s2>Suita</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>National Cardiovascular Center</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lisheng Liu" sort="Lisheng Liu" uniqKey="Lisheng Liu" last="Lisheng Liu">LISHENG LIU</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Division of Hypertension, Fu Wai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>INSERM U708 and the Department of Neurology, Hôpital Lariboisière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name>
<affiliation wicri:level="2"><inist:fA14 i1="05"><s1>Mount Sinai School of Medicine</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Macmahon, Stephen" sort="Macmahon, Stephen" uniqKey="Macmahon S" first="Stephen" last="Macmahon">Stephen Macmahon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rodgers, Anthony" sort="Rodgers, Anthony" uniqKey="Rodgers A" first="Anthony" last="Rodgers">Anthony Rodgers</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</s1>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The George Institute for International Health, the University of Sydney and the Royal Prince Alfred Hospital</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of hypertension</title>
<title level="j" type="abbreviated">J. hypertens.</title>
<idno type="ISSN">0263-6352</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of hypertension</title>
<title level="j" type="abbreviated">J. hypertens.</title>
<idno type="ISSN">0263-6352</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antihypertensive agent</term>
<term>Arterial pressure</term>
<term>Blood pressure</term>
<term>Cardiovascular disease</term>
<term>Cerebrovascular disease</term>
<term>Diuretic</term>
<term>Hypertension</term>
<term>Indapamide</term>
<term>Perindopril</term>
<term>Stroke</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pathologie cérébrovasculaire</term>
<term>Accident cérébrovasculaire</term>
<term>Pathologie de l'appareil circulatoire</term>
<term>Périndopril</term>
<term>Pression artérielle</term>
<term>Pression sanguine</term>
<term>Indapamide</term>
<term>Hypertension artérielle</term>
<term>Antihypertenseur</term>
<term>Diurétique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective To assess the benefits of blood pressure (BP) lowering on vascular events separately for Asian and for Western participants with particular emphasis on stroke subtypes and cardiac outcomes. Methods This is a subsidiary analysis of Perindopril Protection Against Recurrent Stroke Study (PROGRESS), a randomized, placebo-controlled trial that established the benefits of BP lowering in 6105 patients with cerebrovascular disease, randomly assigned to either active treatment (perindopril for all, and indapamide for those with neither an indication for, nor a contraindication to, a diuretic) or placebo(s). Outcomes are total and cause-specific vascular outcomes. Results The annual rates for total major vascular events were 4.2% in Asian and 5.2% in Western participants. Overall stroke rates were greater in Asian compared to Western participants with proportionally more lacunar infarctions and haemorrhagic strokes in Asians and more cardio-embolic infarctions and large artery infarctions in Western participants. Active treatment reduced BP by 10.3/ 4.6 mmHg in Asian, and by 8.1/3.6 mmHg in Western participants. Among Asian participants there was a 38% [95% confidence interval (CI) 23-49%] reduction in major vascular events compared to a 20% (95% CI 7-31%) reduction in Western participants (P homogeneity = 0.06). Similarly, there were higher relative risk reductions for all other outcomes among Asian participants, but this only reached statistical significance for heart failure and vascular death (P= 0.02 for each). The number needed to treat for major vascular events over 5 years was 15 (95% CI 10-26) in Asian compared to 28 (95% CI 17-94) in Western participants (P homogeneity = 0.09). Conclusions BP lowering reduces the risk of major vascular events, with separately significant reductions, in both Asia and the West.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>France</li>
<li>Japon</li>
<li>République populaire de Chine</li>
<li>États-Unis</li>
</country>
<region><li>État de New York</li>
<li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
<li>Pékin</li>
</settlement>
</list>
<tree><country name="Australie"><noRegion><name sortKey="Arima, Hisatomi" sort="Arima, Hisatomi" uniqKey="Arima H" first="Hisatomi" last="Arima">Hisatomi Arima</name>
</noRegion>
<name sortKey="Anderson, Craig" sort="Anderson, Craig" uniqKey="Anderson C" first="Craig" last="Anderson">Craig Anderson</name>
<name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name>
<name sortKey="Macmahon, Stephen" sort="Macmahon, Stephen" uniqKey="Macmahon S" first="Stephen" last="Macmahon">Stephen Macmahon</name>
<name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name>
<name sortKey="Rodgers, Anthony" sort="Rodgers, Anthony" uniqKey="Rodgers A" first="Anthony" last="Rodgers">Anthony Rodgers</name>
</country>
<country name="Japon"><noRegion><name sortKey="Omae, Teruo" sort="Omae, Teruo" uniqKey="Omae T" first="Teruo" last="Omae">Teruo Omae</name>
</noRegion>
</country>
<country name="République populaire de Chine"><noRegion><name sortKey="Lisheng Liu" sort="Lisheng Liu" uniqKey="Lisheng Liu" last="Lisheng Liu">LISHENG LIU</name>
</noRegion>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
</region>
</country>
<country name="États-Unis"><region name="État de New York"><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007644 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007644 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:10-0104497
   |texte=   Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri